June 15, 2025 (Boston) — We are glad to announce that Tony Eglezos, the Commercialisation and Licensing Executive of Starpharma, will be presenting at the ACCESS CHINA BD Forum @BIO on June 15, 2025. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
About the speaker
Tony Eglezos is an experienced Commercialisation and Licensing Executive with a proven record of Leadership and global experience across Australia, the United States, and Europe. Tony has held senior leadership roles at leading companies including CSL, Amgen, Abbott Laboratories, and Abbott Australasia.Tony has extensive experience in acquisitions, due diligence, product commercialisation, global R&D partnerships and management of commercial teams.Tony holds a PhD in Immunology from the University of Melbourne and an MBA from the University of Technology Sydney.
About ACCESS CHINA BD Forum @BIO
‘ACCESS CHINA BD Forum @BIO is scheduled to be held on June 15, 2025, at Seaport Boston Hotel. This year’s ACCESS CHINA BD Forum @BIO will convene 80 distinguished guests for an afternoon of strategic networking, business development, and thought leadership, with a special emphasis on China’s dynamic biotechnology landscape and global collaboration opportunities.
Conference Name: ACCESS CHINA BD Forum @BIO
Date: June 15, 2025
Content: Keynote Speeches, Panel Discussion, 10 Elevator Pitch, and Closed-Door Dinner Reception.
Participants: Pharma/Biotech senior management and BD’s
View more information at https://biotochina.org/
MORE INFORMATION
Contact us:
To register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
BioToChina.org 